Molecular Therapy
The four MT journals are the official journals of ASGCT

View the family homepage Submit Your Research

Claim Your Molecular Therapy Subscription

ASGCT members receive online subscriptions to the Molecular Therapy journals to stay up to date on the latest research in the field. Here's how to claim your subscription:

  1. Sign into your ASGCT account.

  2. Navigate to the Membership Dashboard.

  3. Click on the Molecular Therapy link.

Claim Your Subscription

Molecular Therapy Family

Molecular Therapy

MT is dedicated to publishing important peer-reviewed research and cutting-edge reviews and commentaries promoting genetics, medicine, and biotechnology.

View Current Issue

MT–Methods & Clinical Development

MTM focuses on advances in cell and gene therapy and how they are translated and applied in the clinical setting.

View Current Issue

MT–Nucleic Acids

MTNA publishes top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease.

View Current Issue

MT–Oncolytics

MTO focuses on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer.

View Current Issue

Aims and Scope

Learn more about and submit your research to any of the four journals.

Learn More

Editorial Contacts

Contact the editors-in-chief of each journal as well as Cell Press communications and advertising staff here.

Contact Editors

Permissions

Want to request permission to use information in Molecular Therapy? Here's how to submit a request.

Request Permission

Ethical Statements

Read Molecular Therapy's ethical statements on authorship, dual submission, competing interests, inclusion and diversity, and more.

Read Statements
2022

ASGCT 25th Annual Meeting

May 16-19, 2022

Learn More

© 2000-2021 All rights reserved. American Society of Gene & Cell Therapy. 

Kentico CMS Development by Reason One | Powered by Kentico

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.